Annual report pursuant to Section 13 and 15(d)

Segment Information

v3.20.1
Segment Information
12 Months Ended
Dec. 31, 2019
Segment Information  
Segment Information

19. Segment Information

The Company operates in two reportable segments, Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development. The accounting policies of the Company’s segments are the same as those described in Note 2. Prior to the sale of National the Company operated in three segments, one which included National, see Note 3. The

following tables summarize, for the periods indicated, operating results, from continued operations by reportable segment ($ in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

    

Dermatology

    

Pharmaceutical and

    

 

    

 

 

Products

 

Biotechnology

 

 

 

Year Ended December 31, 2019

 

Sales

 

Product Development

 

Consolidated

Net revenue

 

$

34,921

 

$

1,708

 

$

36,629

Direct cost of goods

 

 

(10,532)

 

 

 —

 

 

(10,532)

Sales and marketing costs

 

 

(17,120)

 

 

 —

 

 

(17,120)

Research and development

 

 

 —

 

 

(81,326)

 

 

(81,326)

General and administrative

 

 

(2,556)

 

 

(35,914)

 

 

(38,470)

Other income

 

 

 —

 

 

9,159

 

 

9,159

Segment gain (loss) from operations

 

$

4,713

 

$

(106,373)

 

$

(101,660)

Segment assets

 

 

 

 

 

 

 

 

 

Intangible assets, net

 

$

7,377

 

$

 —

 

$

7,377

Tangible assets

 

 

19,946

 

 

199,099

 

 

219,045

Total segment assets

 

$

27,323

 

$

199,099

 

$

226,422

 

 

 

 

 

 

 

 

 

 

 

 

    

Dermatology

    

Pharmaceutical and

    

 

    

 

 

Products

 

Biotechnology

 

 

 

Year Ended December 31, 2018

 

Sales

 

Product Development

 

Consolidated

Net Revenue

 

$

23,376

 

$

3,506

 

$

26,882

Direct cost of goods

 

 

(6,125)

 

 

 —

 

 

(6,125)

Sales and marketing costs

 

 

(11,639)

 

 

 —

 

 

(11,639)

Research and development

 

 

 —

 

 

(87,383)

 

 

(87,383)

General and administrative

 

 

(1,778)

 

 

(39,954)

 

 

(41,732)

Other expense

 

 

 

 

 

(10,803)

 

 

(10,803)

Segment gain (loss) from operations

 

$

3,834

 

$

(134,634)

 

$

(130,800)

Segment assets

 

 

 

 

 

 

 

 

 

Intangible assets, net

 

$

1,417

 

$

 —

 

$

1,417

Tangible assets

 

 

8,984

 

 

130,592

 

 

139,576

Total segment assets

 

$

10,401

 

$

130,592

 

$

140,993